Results 211 to 220 of about 3,318,021 (296)

Potential Survival Benefit of Neoadjuvant Docetaxel, Cisplatin and 5‐Fluorouracil Therapy in Patients With Esophageal Squamous Cell Carcinoma With Multiple Lymph Node Metastases: A Single‐Institute Propensity Score Analysis

Annals of Gastroenterological Surgery, EarlyView.
Although neoadjuvant chemotherapy with fluorouracil, cisplatin, and docetaxel (NAC‐DCF) is the current standard neoadjuvant regimen for esophageal squamous cell carcinoma, its substantial toxicity underscores the need to identify patients who derive the greatest benefit.
Eiji Higaki, Tetsuya Abe, Hironori Fujieda, Shigenori Kadowaki, Tsutomu Tanaka, Masahiro Tajika, Koji Komori, Seiji Ito, Isao Oze, Kei Muro   +9 more
wiley   +1 more source

Lung cancer screening care pathways in community settings: an examination of 3 healthcare systems. [PDF]

Ann Am Thorac Soc
Walsh C, Palazzo L, Hansell L, Louie T, Long S, Brown M, Hippe DS, Coronado GD, Decell K, Leone RJ, Lodhi S, Wysham N, Wernli KJ, Triplette M.   +13 more
europepmc   +1 more source

Can Machine Learning Reduce Unnecessary Surgeries? A Retrospective Analysis Using Threshold Optimization to Prevent Negative Appendectomies in Adults

Annals of Gastroenterological Surgery, EarlyView.
Threshold‐optimized machine learning models using routine clinical and laboratory data in 623 adults undergoing appendectomy. Logistic regression (AUC = 0.765) and random forest (AUC = 0.785) were the best‐performing models for appendicitis detection and complicated appendicitis prediction, respectively.
Ivan Males, Marko Kumric, Zvonimir Boban, Josip Vrdoljak, Dario Pecenkovic, Matej Ivanda, Marko Grahovac, Zenon Pogorelic, Josko Bozic   +8 more
wiley   +1 more source

Generative Artificial Intelligence and Large Language Models in Clinical Oncology. [PDF]

MedComm (2020)
Yu Y, Zhao Z, Wang Z, Lin R, Tan Y, Chen Y, Li T, Baptista-Hon D, Zhang X, Wu C, Tong M, Zheng L, Wu J, Monteiro O, Zhang K.   +14 more
europepmc   +1 more source

Clinical Significance of PD‐L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy

Annals of Gastroenterological Surgery, EarlyView.
This study evaluated immune‐related biomarkers in esophageal squamous cell carcinoma treated with immune checkpoint inhibitors after postoperative recurrence. PD‐L1 expression in tumor‐associated macrophages and tumor cells, together with HLA class I downregulation and HLA‐DR expression, were associated with favorable responses to immunotherapy.
Kosuke Kanemitsu, Yoshiyuki Tagayasu, Yoshihiro Komohara, Cheng Pan, Rin Yamada, Yukio Fujiwara, Kazuto Harada, Keisuke Kosumi, Yoshifumi Baba, Masaaki Iwatsuki   +9 more
wiley   +1 more source

Beyond the algorithm: embedding ethics for trustworthy AI in radiology and oncology. [PDF]

Front Digit Health
Cano Abadía M, Goisauf M.
europepmc   +1 more source

Systematic Review and Meta‐Analysis on the Efficacy and Safety of Salvage Esophagectomy for T4 Esophageal Squamous Cell Carcinoma

Annals of Gastroenterological Surgery, EarlyView.
This meta‐analysis of 208 cases shows that salvage esophagectomy for cT4 esophageal squamous cell carcinoma achieves a 72% R0 resection rate, offering a curative pathway for selected patients. However, it remains a high‐risk procedure with an 18% anastomotic leak rate and 30% major complications (Clavien–Dindo ≥ III).
Makoto Sakai, Kengo Kuriyama, Kazue Nagai, Ken Shirabe, Hiroshi Saeki   +4 more
wiley   +1 more source

Recording interventionalists' occupational dose by clinical procedure: a novel approach to radiation safety. [PDF]

CVIR Endovasc
Sanchez RM, Vaño Carruana E, Fernández Soto JM.   +2 more
europepmc   +1 more source

Very Long‐Term Outcomes of Laparoscopic Adjustable Gastric Banding in a Japanese Cohort: A Single‐Center 15‐Year Follow‐Up Study

Annals of Gastroenterological Surgery, EarlyView.
Long‐term outcomes of laparoscopic adjustable gastric banding (LAGB) in Japan were retrospectively evaluated in 28 patients with up to 15 years of follow‐up. LAGB achieved sustained long‐term weight reduction in selected patients; however, recurrence of metabolic comorbidities increased during extended follow‐up.
Yuichi Endo, Hiroomi Takayama, Wataru Miyoshino, Shun Nakamura, Yuiko Nagasawa, Masahiro Kawamura, Yoko Kawano, Takashi Masuda, Teijiro Hirashita, Yoshinori Ozeki, Takayuki Masaki, Hirotaka Shibata, Masafumi Inomata   +12 more
wiley   +1 more source

Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in Canada. [PDF]

Commun Med (Lond)
Safieh-Garabedian N, Antoniou AC, Brooks J, Carroll J, Cavaillé M, Chiquette J, DeCoteau MJ, Doyle G, Eisen A, Eloy L, Feinberg S, Freitas V, Hender K, Kulkarni S, Mbuya-Bienge C, Molnar C, Nabi H, Samson C, Seely JM, Sheppard AJ, Soucy P, Tagyen R, Trop I, Turgeon A, Venturi M, Wadden N, Walker M, Wolfson M, Chiarelli A, Simard J, Pashayan N.   +30 more
europepmc   +1 more source